Histological studies in rats and dogs have demonstrated decreased osteoblast activity, osteoclast numbers, and bone formation rate at sites of high marrow fat when compared to sites of low marrow fat.
Interestingly, these studies reported consistent injuries and high rates of bone marrow oedema when compared to the remaining literature, and suggested a careful progression to MFW should be prescribed at all times.
First, we found no differences in the generation of DCs from Jak3−/− bone marrow progenitors, when compared to wild type cells.
There was a statistically significant increase (none-parametric student's t-test) in target copies per ml in bone marrow samples when compared to blood samples.
An increase in the proportion of CCSP+ cells was found in the bone marrow of CF patients when compared to lung donors (CF median = 1.33%, Donor median = 0.98, p < 0.05).
G-CSF is capable of accelerating myeloid engraftment in patients receiving monoclonal antibody purged bone marrow grafts following myeloablative therapy when compared to historical control groups treated with placebo or GM-CSF.
In bone marrow samples from 5T multiple myeloma diseased mice, a statistically significant increase of the microvessel density was observed when compared to bone marrow samples from age-matched controls.
Despite the latter finding, the combined treatment with PRP resulted in significantly better outcomes in terms of functional scores (AOFAS, FAAM overall pain domain, FAAM 15-min walking domain, and pain-related scores) when compared to bone marrow stimulation alone.
This finding is substantiated by our observation of increased expression of CIB1 in megakaryocytes treated with thrombopoietin (TPO) when compared to bone marrow mononuclear cells.
In addition, bone marrow from older humans is less efficient at reconstituting recipients when compared to the reconstitution capacity of bone marrow derived from younger patients [ 49].
